Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
A pilot study to assess the feasibility of a RCT to compare the effectiveness of two different progesterone only pills (POP) on reducing pelvic pain
ISRCTN ISRCTN42638345
ClinicalTrials.gov identifier
Public title A pilot study to assess the feasibility of a RCT to compare the effectiveness of two different progesterone only pills (POP) on reducing pelvic pain
Scientific title
Acronym N/A
Serial number at source N0530128908
Study hypothesis This pilot study aims to assess if data collected supports the theoretical superiority of Cerazette over Femulen in reducing cyclical pelvic pain. It also aims to assess the feasibility of conducting a larger trial in the future.
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled pilot study
Countries of recruitment United Kingdom
Disease/condition/study domain Urological and Genital Diseases: Pelvic pain
Participants - inclusion criteria 1. Females over 18 years of age who require a method of contraception
2. Willing to follow protocol
3. Able to give written consent
Participants - exclusion criteria Not provided at time of registration
Anticipated start date 01/03/2003
Anticipated end date 30/03/2004
Status of trial Completed
Patient information material
Target number of participants 25
Interventions Comparison of two different progesterone only pills, Cerazette and Femulen
Primary outcome measure(s) If Cerazette is effective in reducing the pain associated with ovulation and menstruation, it will provide a valuable alternative choice for women who are unable to chose not to take combined oral contraceptives (COCs).
Secondary outcome measure(s) Not provided at time of registration
Sources of funding North Central London Research Consortium (UK)
Trial website
Publications
Contact name Dr  Jo  Power
  Address Margaret Pyke Centre
73 Charlotte Street
  City/town London
  Zip/Postcode W1T 4PL
  Country United Kingdom
  Tel +44 (0)20 7 530 3640
  Fax +44 (0)20 7 580 2495
  Email jopower1@hotmail.com
Sponsor Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)
  Address The Department of Health,
Richmond House,
79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.dh.gov.uk/Home/fs/en
Date applied 30/09/2004
Last edited 30/04/2010
Date ISRCTN assigned 30/09/2004
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central